Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Lee Jackson | Feb 26, 2021 at 7:58 AM EST

Interest Rates Explode Higher: 5 Safe Dividend Stocks to Buy Now

These five BofA Securities high-quality stock picks have good prospects for the rest of 2021 and should continue to be…

Chris Lange | Jan 24, 2021 at 6:15 AM EST

Apple, Boeing, Caterpillar, Microsoft and More Major Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week,…

Lee Jackson | Dec 28, 2020 at 8:50 AM EST

Why 5 Dividend-Paying Dow Jones Industrials Are Great 2021 Stocks to Buy

While positive earnings could continue to drive the major indexes higher in 2021, a very overbought and fully valued market…

Lee Jackson | Dec 10, 2020 at 9:50 AM EST

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may…

Jon C. Ogg | Nov 17, 2020 at 6:49 AM EST

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.

Lee Jackson | Oct 14, 2020 at 8:29 AM EDT

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These…

Chris Lange | Oct 13, 2020 at 10:56 AM EDT

Are Earnings Enough to Counter COVID-19 Study Setback at Johnson & Johnson?

Johnson & Johnson released better than expected quarterly results before the markets opened on Tuesday, but it also announced a…

Chris Lange | Oct 11, 2020 at 6:15 AM EDT

Citigroup, Goldman Sachs, Johnson & Johnson, Walgreens and More Major Earnings This Week

A new earnings reporting season kicks off this week, with the big banks and a few other companies leading the…

Chris Lange | Oct 2, 2020 at 11:58 AM EDT

Where We Stand on a Vaccine After Trump Catches COVID-19

President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of…

Lee Jackson | Sep 30, 2020 at 7:42 AM EDT

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…

Jon C. Ogg | Sep 23, 2020 at 10:48 AM EDT

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of…

Jon C. Ogg | Sep 8, 2020 at 3:27 PM EDT

What Does a Perfect COVID-19 Vaccine Actually Mean?

The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…

Jon C. Ogg | Sep 2, 2020 at 7:27 PM EDT

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

America and the rest of the world is getting ready for a vaccine that will help protect public health against…

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Chris Lange | Aug 19, 2020 at 11:33 AM EDT

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared…

1 … 16 17 18 19 20 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Interest Rates Explode Higher: 5 Safe Dividend Stocks to Buy Now

Apple, Boeing, Caterpillar, Microsoft and More Major Dow Earnings Coming This Week

Why 5 Dividend-Paying Dow Jones Industrials Are Great 2021 Stocks to Buy

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Are Earnings Enough to Counter COVID-19 Study Setback at Johnson & Johnson?

Citigroup, Goldman Sachs, Johnson & Johnson, Walgreens and More Major Earnings This Week

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

What Does a Perfect COVID-19 Vaccine Actually Mean?

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Interest Rates Explode Higher: 5 Safe Dividend Stocks to Buy Now

Apple, Boeing, Caterpillar, Microsoft and More Major Dow Earnings Coming This Week

Why 5 Dividend-Paying Dow Jones Industrials Are Great 2021 Stocks to Buy

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Are Earnings Enough to Counter COVID-19 Study Setback at Johnson & Johnson?

Citigroup, Goldman Sachs, Johnson & Johnson, Walgreens and More Major Earnings This Week

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

What Does a Perfect COVID-19 Vaccine Actually Mean?

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%